CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −159 | $587.00 | $93K | 333,784 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −323 | $588.30 | $190K | 333,461 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −427 | $589.21 | $252K | 333,034 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −359 | $590.11 | $212K | 332,675 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −317 | $591.10 | $187K | 332,358 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −551 | $592.32 | $326K | 331,807 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,934 | $593.44 | $1.1M | 329,873 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −3,079 | $594.24 | $1.8M | 326,794 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,409 | $595.17 | $839K | 325,385 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −662 | $596.22 | $395K | 324,723 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −280 | $597.33 | $167K | 324,443 |
| 2026-11-12 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 33,910 | ||
| 2026-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −25 | $584.20 | $15K | 333,918 |
| 2026-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −215 | $585.93 | $126K | 333,703 |
| 2026-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −320 | $586.59 | $188K | 333,383 |
| 2026-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −271 | $588.16 | $159K | 333,112 |
| 2026-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −292 | $589.18 | $172K | 332,820 |
| 2026-11-11 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −301 | $590.31 | $178K | 332,519 |
Page 1 of 121 · 2,404 trades